CDKN1B and atherosclerosis: Increased expression of CDKN1B is associated with structural and functional changes in the kidneys in diabetic nephropathy [64], decreased pancreatic β-cell proliferation and serum insulin levels [60], as well as decreased macrophage proliferation and inflammation in atherosclerosis [65].